Virtually reducing fall risk in Parkinson disease

Falls are common and often represent devastating events for patients with advanced Parkinson disease (PD). Prospective studies report that 70% of people with PD have at least one fall in a year, and that 39% fall recurrently. Falls have serious consequences (fractures and other injury, hospital admission, fear of falls, and an increase in caregiver burden).1,2 The few available treatment options are not highly effective.

[1]  Jeffrey M. Hausdorff,et al.  Disparate effects of training on brain activation in Parkinson disease , 2017, Neurology.

[2]  A. Lampit,et al.  Cognitive Training in Parkinson’s Disease , 2017, Neurorehabilitation and neural repair.

[3]  Lynn Rochester,et al.  Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall‐naïve cohort , 2016, Movement disorders : official journal of the Movement Disorder Society.

[4]  Jeffrey M. Hausdorff,et al.  Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial , 2016, The Lancet.

[5]  Y Ben-Shlomo,et al.  Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial , 2016, The Lancet Neurology.

[6]  Cathi A Thomas,et al.  Highly Challenging Balance Program Reduces Fall Rate in Parkinson Disease , 2016, Journal of neurologic physical therapy : JNPT.

[7]  Y. Ben-Shlomo,et al.  Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013. , 2015, Parkinsonism & related disorders.

[8]  Natalie E. Allen,et al.  Exercise for falls prevention in Parkinson disease , 2015, Neurology.

[9]  Natalie E. Allen,et al.  Recurrent Falls in Parkinson's Disease: A Systematic Review , 2013, Parkinson's disease.

[10]  L. Defebvre,et al.  Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial , 2012, The Lancet Neurology.